Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/05/2858497/0/en/Protara-Therapeutics-Announces-Oversubscribed-45-Million-Private-Placement-Financing.html
https://www.globenewswire.com/news-release/2024/04/05/2858495/0/en/Protara-Therapeutics-Announces-Alignment-with-FDA-on-Registrational-Path-Forward-for-IV-Choline-Chloride-in-Patients-Dependent-on-Parenteral-Nutrition.html
https://www.globenewswire.com/news-release/2024/04/05/2858487/0/en/Protara-Therapeutics-Announces-Positive-Three-Month-Data-from-TARA-002-Clinical-Program-in-NMIBC.html
https://www.globenewswire.com//news-release/2024/03/13/2845381/0/en/Protara-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/28/2836905/0/en/Protara-Therapeutics-to-Present-at-the-TD-Cowen-44th-Annual-Health-Care-Conference.html
https://www.globenewswire.com/news-release/2024/01/31/2820998/0/en/Protara-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2023/11/30/2788580/0/en/Protara-Therapeutics-Announces-Presentation-of-Additional-Encouraging-Data-from-Phase-1a-ADVANCED-1-Trial-of-TARA-002-in-NMIBC-at-the-24th-Annual-Meeting-of-the-Society-of-Urologic.html
https://www.globenewswire.com//news-release/2023/11/03/2773140/0/en/Protara-Therapeutics-Announces-Third-Quarter-2023-Financial-Results-and-Business-Update.html
https://www.globenewswire.com//news-release/2023/10/23/2764652/0/en/Protara-Therapeutics-Announces-Dosing-of-First-Patient-in-Phase-2-STARBORN-1-Trial-of-TARA-002-in-Pediatric-Patients-with-Lymphatic-Malformations.html
https://www.globenewswire.com//news-release/2023/09/20/2746463/0/en/Protara-Therapeutics-Announces-Dosing-of-First-Patient-in-Phase-1b-2-ADVANCED-2-Trial-of-TARA-002-in-NMIBC-Patients-with-High-Grade-Carcinoma-in-Situ.html